LaborMed Pharma SA
Labor Med Pharmacy SA (Labor Med Pharmacy) is a Romanian pharmaceutical company, primarily engaged in the research, production, and distribution of generic pharmaceutical products targeted at cardiovascular diseases. Its product portfolio includes 80 modern generic, of which 70 of them are identified by its own brand. Additionally, Labor Med Pharmacy covers five other therapy areas, moreover concentrating on oral anti-diabetics and on treatments of the central nervous systems diseases. It provides Gliclazid MR LPH, an oral anti-diabetics product for patients with type 2 diabetes mellitus and typical phenotype. Apart from Romania, Labor Med Pharmacy operates in foreign market principally in Bulgaria, the Republic of Mold ova, the Russian Federation, Belarus, and Georgia. Labor Med Pharmacy offers products for pharmacies and hospitals through its own distribution network, comprising eight branches. The company has acquired Ozone Laboratories in July, 2009. Labor Med Pharmacy is a Labor med Pharmacy Group company and is headquartered in Bucharest, Romania.